Fuchs Heterochromic Iridocyclitis (Fuchs Heterochromic Uveitis) Follow-up

Updated: May 09, 2017
  • Author: Neerav Neel Lamba, MD, MBA; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Further Outpatient Care

Patients should receive follow-up care as needed.



See the list below:

  • Cataracts

  • Secondary glaucoma

  • Vitreous debris that obscures vision

  • Dilated pupil

  • Corneal edema (rare)

  • Retinal detachment (rare)



The low-grade inflammation smolders over decades. Initially, vision is not significantly impaired.

All patients eventually develop cataracts that require surgical removal. Generally, the outcome of cataract surgery with posterior chamber intraocular lens implantation is good. Some patients develop increased inflammation and transient increased intraocular pressure during the postoperative period. Particular care should be given to placement of the intraocular lens within the capsular bag and the use of minimally adherent intraocular lens materials most compatible with uveitis. Acrylic intraocular lenses and surface modified polymethylmethacrylate (PMMA) intraocular lenses appear to be the most desirable materials, while first-generation silicone may create more cellular adhesion and, thus, more inflammation postoperatively.

Secondary glaucoma is not uncommon. This may require surgical therapy if antiglaucoma medications do not control the disease. The success for glaucoma surgery is less than that for primary open-angle glaucoma.

Severe vitreous inflammatory debris not only obscures vision but also may create a capacitance for inflammatory mediators. Thus, elective pars plana vitrectomy may not only improve vision but also reduce long-term inflammatory damage to the posterior segment. Vitrectomy may be performed concomitantly with cataract extraction and intraocular lens implantation or as a subsequent procedure.